The peptide hormone glucagon forms amyloid fibrils with two coexisting β-strand conformations-Reference-Cited by-同舟云学术

The peptide hormone glucagon forms amyloid fibrils with two coexisting β-strand conformations

Published:2019-06-24 Issue:7 Volume:26 Page:592-598
ISSN:1545-9993
Container-title:Nature Structural & Molecular Biology
language:en
Short-container-title:Nat Struct Mol Biol

Author:

Gelenter Martin D.,Smith Katelyn J.,Liao Shu-Yu,Mandala Venkata S.,Dregni Aurelio J.,Lamm Matthew S.,Tian Yu^ORCID,Xu Wei,Pochan Darrin J.,Tucker Thomas J.,Su Yongchao^ORCID,Hong Mei^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Structural Biology

Link

http://www.nature.com/articles/s41594-019-0238-6.pdf

Reference62 articles.

1. Chiti, F. & Dobson, C. M. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu. Rev. Biochem. 86, 27–68 (2017).

2. Frokjaer, S. & Otzen, D. E. Protein drug stability: a formulation challenge. Nat. Rev. Drug Discov. 4, 298 (2005).

3. Brange, J., Andersen, L., Laursen, E. D., Meyn, G. & Rasmussen, E. Toward understanding insulin fibrillation. J. Pharm. Sci. 86, 517–525 (1997).

4. Habegger, K. M. et al. The metabolic actions of glucagon revisited. Nat. Rev. Endocrinol. 6, 689 (2010).

5. Caputo, N. et al. Mechanisms of glucagon degradation at alkaline pH. Peptides 45, 40–47 (2013).

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The structure of mouse RIPK1 RHIM-containing domain as a homo-amyloid and in RIPK1/RIPK3 complex;Nature Communications;2024-08-14

2. Hypoglycemia and Alzheimer Disease Risk: The Possible Role of Dasiglucagon;Cellular and Molecular Neurobiology;2024-07-08

3. Atomic resolution structure of full-length human insulin fibrils;Proceedings of the National Academy of Sciences;2024-05-29

4. Industrial Horizons in Pharmaceutical Science;Molecular Pharmaceutics;2024-05-29

5. Ultra-stable insulin-glucagon fusion protein exploits an endogenous hepatic switch to mitigate hypoglycemic risk;2024-05-21